Skip to Content

WW 172 (Captopril 25 mg)

Pill imprint WW 172 has been identified as Captopril 25 mg.

Captopril is used in the treatment of hypertensive emergency; high blood pressure; heart failure; diabetic kidney disease; cystinuria (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Captopril 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Captopril 25 mg WW 172
Captopril 25 mg WW 172  Front
Captopril 25 mg WW 172  Back
WW 172
25 mg
8.00 mm
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
West-Ward Pharmaceutical Corporation
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
silicon dioxide
microcrystalline cellulose
sodium starch glycolate type A potato
corn starch
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0043 McKesson Packaging Services
00904-5046 Major Pharmaceuticals
54569-4246 A-S Medication Solutions, LLC (repackager)
63874-0347 Altura Pharmaceuticals Inc (repackager)
68115-0059 Dispensexpress Inc (repackager)
66336-0946 Dispensing Solutions Inc. (repackager)
23490-5193 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.